Tempus AI, Inc. (trading under the Nasdaq ticker symbol TEM) is a technology-driven healthcare enterprise that leverages artificial intelligence and machine learning to advance precision medicine. By combining clinical genomic testing with one of the world's largest repositories of multimodal medical data, the company helps doctors make personalized treatment decisions for cancer patients while simultaneously providing pharmaceutical developers with critical insights to accelerate drug discovery and clinical research trials.